SEC Form 4 · accession 0001493152-26-039702
Hepion Pharmaceuticals, Inc. · HEPA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Vincent S LoPriore
Officer — Executive Chairman · Director
Period of report
Aug 19, 2026
Accepted (ET)
Aug 21, 2026 · 4:34 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001583771
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionsF1 | $0.08 | Aug 19, 2026 | A | 1,345,500 | A | Aug 19, 2026 | Aug 19, 2036 | Common Stock | 1,345,500 | 1,345,500 | D |
Explanation of responses
- F1336,375 options vest upon grant and the remaining amount vests in equal amounts monthly over 6 months from date of grant.